Prothya Biosolutions

CompanyNetherlands

ROR

Prothya Biosolutions develops one asset, in phase 3, no development reported (Immune Globulin IV (Human), 10% Caprylate/Chromatography Purified in chronic inflammatory demyelinating polyneuropathy). Mostly plasma or blood product; based in Netherlands.

1
Asset
Furthest stage
Phase 3, no development reported
2
Trials
25
Signals

Pipeline

1

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials6
  • People1
  • Signals20
  • Similar companies6

Intelligence